Earkart IPO: Things Smart Investors Need to Know

    Earkart Limited, a HealthTech company, operates in the niche segment of hearing aids and assistive devices. The company offers a wide portfolio of modern hearing solutions such as Receiver-In-Canal (RIC), Invisible (IIC), Behind-The-Ear (BTE), In-The-Ear (ITE), In-The-Canal (ITC), and Completely-In-Canal (CIC) devices. Alongside hearing aids, it also distributes products like adjustable foldable walkers and Multi-Sensory Integrated Educational Development (MSIED) and Teaching Learning Material (TLM) aimed at supporting physically challenged individuals. With its network of partners and clinics in India and abroad, Earkart has steadily built its presence in both consumer and government segments.

    The company is also a registered supplier on the Government e-Marketplace (GeM), providing hearing aids to ALIMCO under the Ministry of Social Justice and Empowerment. In April 2024, it introduced a Shop in Shop (SIS) model, partnering with opticians and ENT/optical clinics to widen its reach. Currently, Earkart operates 49 SIS clinics across 22 cities in multiple states and Union Territories. Its 4,500 sq. ft. Noida facility underpins its manufacturing capabilities. With strengths in diverse product offerings, multi-channel distribution, and a focus on technology-driven innovation, the upcoming IPO offers an opportunity for investors to evaluate the company’s role in a steadily expanding sector.

    For more details, visit the Earkart IPO page.

    Earkart IPO Details and Objectives

    Details

    Information

    IPO Date

    September 25, 2025 to September 29, 2025

    Issue Size

    36,49,000 shares

    (aggregating up to ₹49.26 Cr)

    Price Band

    ₹135 per share

    Lot Size

    1000 shares

    Listing At

    SME BSE

    Market Maker

    Rikhav Securities Ltd.

    Purpose of the IPO

    • Funding incremental working capital requirements of our Company

    • Funding capital expenditure requirements for setting of Shop in Shop (SIS) Business Model in ENT/Ophthalmic Clinics across India and Setting up of Infrastructure for operational activities

    • General corporate purposes

    Timeline of Earkart IPO

    Event

    Date

    IPO Open Date

    Thu, Sep 25, 2025

    IPO Close Date

    Mon, Sep 29, 2025

    Tentative Allotment

    Tue, Sep 30, 2025

    Initiation of Refunds

    Wed, Oct 1, 2025

    Credit of Shares to Demat

    Wed, Oct 1, 2025

    Tentative Listing Date

    Fri, Oct 3, 2025

    Cut-off time for UPI mandate confirmation

    5 PM on Mon, Sep 29, 2025

    Pricing & Lot Size of Earkart IPO

    Price Band for the IPO

    •  ₹135 per share

    Minimum Lot Size and Application Details

    Application

    Lots

    Shares

    Amount

    Individual investors (Retail) (Min)

    2

    2,000

    ₹2,70,000

    Individual investors (Retail) (Max)

    2

    2,000

    ₹2,70,000

    HNI (Min)

    3

    3,000

    ₹4,05,000

    How to Apply for the Earkart IPO?

    Online Application Process

    • Log in to Your Trading Account
      Access your trading account through your broker’s platform.

    • Navigate to the IPO Section
      Go to the IPO section to view active IPO listings.

    • Select Earkart IPO
      Find "Earkart IPO" and click on the ‘Apply’ button.

    • Enter Application Details
      Specify the number of lots (minimum lot size: 1000 shares) and the bid price within the range of ₹135 per share.

    • Provide Your UPI ID
      Enter your UPI ID for payment authorization. Ensure that sufficient funds are available in your linked account.

    • Review and Submit
      Verify all the details entered before submitting the application. Approve the UPI mandate before 5 PM on September 29, 2025, to complete your application process.

    Additional Read- How to Apply for the Earkart IPO?

    Financial Health and Performance

    Key Financial Metrics

    • Total Assets: Grew from ₹14.73 crore in FY23 to ₹30.29 crore as of March 2025.

    • Total income: Reached ₹43.19 crore in FY25.

    • Profit After Tax (PAT): Stood at ₹6.88 crore for March 2025.

    • Net Worth: Recorded at ₹19.92 crore in FY25.

    • Reserves and Surplus: Recorded at ₹4.96 crore (March 2025), growing steadily over the years.

    • EBITDA: Stood at ₹9.76 crore in March 2025.

    Recent Performance and Growth Prospects

    • The company has demonstrated consistent growth in its asset base, reflecting its ability to scale operations over recent years.

    • Revenues have expanded steadily, indicating strong demand for its products and services across different market segments.

    • Profitability has improved, showing efficient cost management and a healthy financial structure.

    • The company’s net worth has strengthened, highlighting improved shareholder value and financial resilience.

    • Reserves and surplus have grown steadily, providing a solid foundation for future expansion and investment.

    • Operating performance has shown stability, supported by robust earnings before interest, tax, depreciation, and amortisation.

    Investment Risks and Opportunities

    Potential Risks of Investing in the IPO

    • The company operates in a specialised segment, which may face challenges from technological shifts, evolving consumer preferences, or competition from established global players.

    • Expansion plans such as the Shop in Shop (SIS) model require continuous investment and execution efficiency, and any delays or disruptions could affect growth.

    Opportunities and Growth Potential

    • The company has a diverse product portfolio, a multi-channel distribution system, and government partnerships, creating avenues for long-term market presence.

    • Growing awareness about hearing health and increasing demand for assistive devices position the company to expand its reach in both domestic and international markets.

    Key Performance Indicator (KPI)

    KPI

    Values

    ROE

    34.55%

    ROCE

    47.32%

    Debt/Equity

    0.26

    RoNW

    34.55%

    PAT Margin

    15.93%

    EBITDA Margin

    22.65%

    Price to Book Value

    7.08

    Earkart IPO Registrar & Lead Managers

    Registrar

    Lead Manager(s)

    Skyline Financial Services Pvt.Ltd.

    Sarthi Capital Advisors Pvt.Ltd.

    Company Address of Earkart Ltd

    Earkart Ltd. Shop No. 8-P, Street No. 6, Vasundhara Enclave, East Delhi, New Delhi, 110096
    Phone: 0120-4102857
    Email: cs@earkart.in
    Website: https://www.earkart.in/

    Conclusion

    The Earkart IPO brings forward the company’s journey in the HealthTech sector, where it has established a presence in hearing aids, assistive devices, and allied products. Its business approach combines product variety, government partnerships, and a multi-channel distribution system that connects with both consumer and institutional markets.

    With recent initiatives like the Shop in Shop model and a steady operational footprint, the IPO aims to support working capital, infrastructure expansion, and broader business objectives outlined in its filing.

    Interested in more opportunities? Check out our Upcoming IPO section for new listings, and don’t forget to check your IPO allotment status for Earkart IPO. 

    Share this article: 

    Frequently Asked Questions

    Disclaimer :

    Investments in securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.


    The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes. The securities are quoted as an example and not as a recommendation. Past performance is not necessarily a guide to future performance.

    The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and/or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.

    Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.

    BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.



    Content Partner - Dalal Street Investment Journal Wealth Advisory Private Limited



    This article is for educational purposes only and should not be considered investment advice. Market investments are subject to risks. DSIJ Wealth Advisory Private Limited is a SEBI-registered Research Analyst (Reg. No: INH000006396) and Investment Adviser (Reg. No: INA000001142). Please consult your financial adviser before investing. 

    For more disclaimer, check here : https://www.bajajbroking.in/disclaimer

    Read More Blogs

    Publish Date: 25 Sep 2025

    Our Secure Trading Platforms

    Level up your stock market experience: Scan the QR to download the Bajaj Broking App for effortless investing and trading

    Scan the QR code to download Bajaj Broking App

    1 M+ Users

    4.8 App Rating

    4 Languages

    ₹8,422 Cr+ MTF Book

    Open Your Free Demat Account

    Access Research Backed Stock Recommendations

    +91

    |

    Open Your Free Demat Account

    Access Research Backed Stock Recommendations

    +91

    |